Agilent Technologies (Denmark)

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

• Biochemistry, Genetics and Molecular Biology 4.2×
• Medicine 3.6×
• Neuroscience 2.4×
• Environmental Science 0.7×
• Materials Science 0.6×

By volume in 2022–2025: HER2/EGFR in Cancer Research, Lung Cancer Diagnosis and Treatment, Cholangiocarcinoma and Gallbladder Cancer Studies and Lung Cancer Treatments and Mutations.

1. 1 HER2/EGFR in Cancer Research Oncology 0 works
2. 2 Lung Cancer Diagnosis and Treatment Pulmonary and Respiratory Medicine 0 works
3. 3 Cholangiocarcinoma and Gallbladder Cancer Studies Surgery 0 works
4. 4 Lung Cancer Treatments and Mutations Pulmonary and Respiratory Medicine 0 works
5. 5 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 0 works
6. 6 Radiomics and Machine Learning in Medical Imaging Radiology, Nuclear Medicine and Imaging 0 works
7. 7 Advanced Biosensing Techniques and Applications Molecular Biology 0 works
8. 8 Glycosylation and Glycoproteins Research Molecular Biology 0 works
9. 9 Insect and Arachnid Ecology and Behavior Genetics 0 works
10. 10 Physiological and biochemical adaptations Ecology 0 works

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

Output in 2018–2022 was 16% lower than in 2013–2017.

• Glostrup Hospital
• Center for Clinical Research and Prevention
• Grontmij (Denmark)
• TE Connectivity (Denmark)
• Cool Sorption (Denmark)